Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Core Laboratories (CLB) Common Equity (2022 - 2026)

Core Laboratories filings provide 5 years of Common Equity readings, the most recent being $268.9 million for Q1 2026.

  • On a quarterly basis, Common Equity rose 5.89% to $268.9 million in Q1 2026 year-over-year; TTM through Mar 2026 was $268.9 million, a 5.89% increase, with the full-year FY2025 number at $266.0 million, up 5.42% from a year prior.
  • Common Equity hit $268.9 million in Q1 2026 for Core Laboratories, up from $266.0 million in the prior quarter.
  • In the past five years, Common Equity ranged from a high of $277.4 million in Q3 2025 to a low of $173.8 million in Q2 2022.
  • Median Common Equity over the past 5 years was $241.6 million (2024), compared with a mean of $233.7 million.
  • Biggest five-year swings in Common Equity: rose 26.38% in 2023 and later grew 5.42% in 2025.
  • Core Laboratories' Common Equity stood at $183.5 million in 2022, then grew by 22.26% to $224.4 million in 2023, then rose by 12.45% to $252.3 million in 2024, then increased by 5.42% to $266.0 million in 2025, then rose by 1.09% to $268.9 million in 2026.
  • The last three reported values for Common Equity were $268.9 million (Q1 2026), $266.0 million (Q4 2025), and $277.4 million (Q3 2025) per Business Quant data.